Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Yingshi Chen"'
Autor:
Fei Yu, Yingshi Chen, Mo Zhou, Lingling Liu, Bingfeng Liu, Jun Liu, Ting Pan, Yuewen Luo, Xu Zhang, Hailan Ou, Wenjing Huang, Xi Lv, Zhihui Xi, Ruozhi Xiao, Wenyu Li, Lixue Cao, Xiancai Ma, Jingwen Zhang, Lijuan Lu, Hui Zhang
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Acute myeloid leukemia (AML) is caused by clonal disorders of hematopoietic stem cells. Differentiation therapy is emerging as an important treatment modality for leukemia, given its less toxicity and wider applicable population, but the ars
Externí odkaz:
https://doaj.org/article/24e597fbaba345339af0b3a49a54efac
Autor:
Katalin Sandor, Peng Xu, Joseph A Fraietta, Stephan Grupp, Crystal L Mackall, Patrick Quinn, Martina Markovska, Yingshi Chen, Katherine P Mueller, Alexander E Doan, Andy Chen, Geoffrey Rouin, Bence Daniel, John Lattin, Brett Mozarsky, Jose Arias-Umana, Robert Hapke, Inyoung Jung, Dorota Klysz, Malek Bashti, Wenxi Zhang, Junior Hall, Caleb A Lareau, Elena Sotillo, Ansuman T Satpathy, Evan W Weber
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/217a9a8ee6f74a2fb315bf07253d21ba
Autor:
Renfeng Fan, Xiaoyuan Huang, Xuanxuan Nian, Zhiqiang Ou, Jian Zhou, Jiayou Zhang, Peiyu Zeng, Wei Zhao, Jinglong Deng, Wei Chen, Shaomin Chen, Kai Duan, Yingshi Chen, Xinguo Li, Jikai Zhang, Xiaoming Yang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1, Pp 1-9 (2022)
To control seasonal influenza epidemics in elders, a quadrivalent, inactivated, split-virion influenza vaccine (IIV4) comprising A and B lineages is produced for young individuals and adults aged ≥60 years. In this phase III, randomized, double-bli
Externí odkaz:
https://doaj.org/article/2db5b883a1db4437beea75b2f71b4480
Autor:
Fei Yu, Xin He, Weiwei Liu, Yiwen Zhang, Wenjing Huang, Hongrong Hu, Yuzhuang Li, Likai Tan, Yingshi Chen, Zhilin Peng, Yaochang Yuan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Background In the tumor microenvironment, tumor cells are able to suppress antitumor immunity by competing for essential nutrients, including amino acids. However, whether amino acid depletion modulates the activity of CD8+ tumor-infiltrating lymphoc
Externí odkaz:
https://doaj.org/article/9a8ded50479f4ce2a3d1dd5a39eec9f8
Autor:
Yingshi Chen, Shu-Mei Yan, Zeyu Pu, Jinzhu Feng, Likai Tan, Yuzhuang Li, Hongrong Hu, Wenjing Huang, Yingtong Lin, Zhilin Peng, Xin He, Feng Huang, Hui Zhang, Yiwen Zhang
Publikováno v:
Cancer Research. 82:3130-3142
Tissue-resident memory CD8+ T (TRM) cells have been associated with robust protective antitumor immune responses and improved prognosis of patients with cancer. Therefore, therapeutic strategies that modulate either the production or activity of TRM
Autor:
Yiwen Zhang, Hui Zhang, Feng Huang, Xin He, Zhilin Peng, Yingtong Lin, Wenjing Huang, Hongrong Hu, Yuzhuang Li, Likai Tan, Jinzhu Feng, Zeyu Pu, Shu-Mei Yan, Yingshi Chen
Supplementary Data from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a359210392ecb492e09ce858c770cc2
https://doi.org/10.1158/0008-5472.22431897.v1
https://doi.org/10.1158/0008-5472.22431897.v1
Autor:
Yiwen Zhang, Hui Zhang, Feng Huang, Xin He, Zhilin Peng, Yingtong Lin, Wenjing Huang, Hongrong Hu, Yuzhuang Li, Likai Tan, Jinzhu Feng, Zeyu Pu, Shu-Mei Yan, Yingshi Chen
Supplementary Figure from Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::597e2016b5b576b2f0a3792c3d064f08
https://doi.org/10.1158/0008-5472.22431894.v1
https://doi.org/10.1158/0008-5472.22431894.v1
Autor:
Yiwen Zhang, Hui Zhang, Feng Huang, Xin He, Zhilin Peng, Yingtong Lin, Wenjing Huang, Hongrong Hu, Yuzhuang Li, Likai Tan, Jinzhu Feng, Zeyu Pu, Shu-Mei Yan, Yingshi Chen
Tissue-resident memory CD8+ T (TRM) cells have been associated with robust protective antitumor immune responses and improved prognosis of patients with cancer. Therefore, therapeutic strategies that modulate either the production or activity of TRM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a1445beba1fa969f555e984dad51b88
https://doi.org/10.1158/0008-5472.c.6514026
https://doi.org/10.1158/0008-5472.c.6514026
Autor:
Hui Zhang, Fei Yu, Yingshi Chen, Mo Zhou, Jing-Wen Zhang, Lingling Liu, Bingfeng Liu, Jun Liu, Ting Pan, Yuewen Luo, Xu Zhang, Hailan Ou, Wenjing Huang, Xi Lv, Zhihui Xi, Ruozhi Xiao, Lixue Cao, Lijuan Lu, Xiancai Ma
Acute myeloid leukemia (AML) is caused by clonal disorders of hematopoietic stem cells. Differentiation therapy is emerging as an important treatment modality for leukemia, given its less toxicity and wider applicable population, but the arsenal of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::113eba93d0e3cbbfc9ee0029ad147e8f
https://doi.org/10.21203/rs.3.rs-2094714/v1
https://doi.org/10.21203/rs.3.rs-2094714/v1
Publikováno v:
Pigment Cell & Melanoma Research. 35:238-251
Melanoma is highly heterogeneous with diverse genomic alterations and partial therapeutic responses. Emergence of drug-resistant tumor cell clones accompanied with high AXL expression level is one of the major challenges for anti-tumor clinical care.